Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
GRP78/BiP has recently emerged as a novel biomarker for aggressive prostate cancer. Here, we report that homozygous deletion of Grp78 specifically in mouse prostate epithelium suppresses prostate tumorigenesis without affecting postnatal prostate development and growth. Mouse prostates with double conditional knockout of Grp78 and Pten exhibit normal histology and cytology, in contrast to the invasive adenocarcinoma in mouse prostates with Pten inactivation. AKT activation in Pten null prostate epithelium is inhibited by Grp78 homozygous deletion, corresponding with suppression of AKT phosphorylation by GRP78 knockdown in prostate cancer cell line. Thus, inactivation of GRP78 may represent a previously undescribed approach to stop prostate cancer and potentially other cancers resulting from the loss of PTEN tumor suppression and/or activation of the oncogenic AKT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, suppression of BiP signaling by KP1339 (also known as IT‐139) or HA15 in glioblastoma, bladder or breast cancer cell lines has been shown to enhance the response to anti‐cancer therapy [194, 195].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [194]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 1×
“Pten homozygous deletion in mice causes early embryonic death, and Pten / mice exhibit hyperplastic-dysplastic changes in multiple organs, including PIN in mouse prostate but no progression to adenocarcinoma (13).”
BackgroundWang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109 · cited 7×
“transgene and f Pten allele on C57BL/6xDBA2/129 background was described previously (15).”
BackgroundResultSelf-citationTenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034 · cited 1×
“If so, what is the underlying mechanism? One of the most common genes involved in prostate cancer is Pten, a nonredundant phosphatase gene frequently deleted or mutated in human cancers (11).”
BackgroundThe Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921 · cited 1×
“As a result, phosphorylation of a wide range of downstream signaling molecules leads to enhanced cell growth and survival (12).”
BackgroundGRP78 Induction in Cancer: Therapeutic and Prognostic Implications
Lee, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0325 · Cited by 856 · cited 3×
“GRP78 is highly induced in a wide range of tumors through intrinsic factors such as altered glucose metabolism of cancer cells, compounded by extrinsic factors such as glucose deprivation, hypoxia, and acidosis in the microenvironment of poorly-perfused solid tumor (7).”
BackgroundER chaperones in mammalian development and human diseases
Ni, M., & Lee, A. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.045 · Cited by 735 · cited 1×
“As a major endoplasmic reticulum (ER) chaperone, GRP78 facilitates protein folding and assembly, protein quality control, ER-associated protein degradation, Ca2 binding, and regulation of transmembrane ER stress inducers (4, 5).”
BackgroundAging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation
Chambers, S. M., Shaw, C. A., Gatza, C., Fisk, C. J., Donehower, L. A., & Goodell, M. A. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050201 · Cited by 731 · cited 1×
“It is also tempting to speculate that GRP78 may have a role in cancer stem cells, because it is required for survival of embryonic stem cell precursors and is among a set of select genes expressed in hematopoietic stem cells (6, 30).”
BackgroundReddy, R. K., Mao, C., Baumeister, P., Austin, R. C., Kaufman, R. J., & Lee, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212328200 · Cited by 695 · cited 1×
“In addition to maintenance of ER homeostasis through protein quality control and serving as an ER Ca2 binding protein, GRP78 with antiapoptotic properties is known to protect cancer cells against immune surveillance (25), and directly interacts with and inhibits caspase-7 (26).”
BackgroundSelf-citationStress Induction of GRP78/BiP and Its Role in Cancer
Li, J., & Lee, A. (2006) · Current Molecular Medicine · doi:10.2174/156652406775574523 · Cited by 599
The ER function BiP is a master regulator of ER function.
Hendershot, L. M. (2004) · PubMed · Cited by 542
Research works printed but not linked: 1
- Fu et al. PNAS ͉ December 9, 2008 ͉ vol. 105 ͉ no. 49 ͉ 19449 MEDICAL SCIENCES
Cited by
Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease
Cao, S. S., & Kaufman, R. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5851 · Cited by 1,363
“In addition, conditional knockout of Bip in the prostate of mice with Pten inactivation suppressed prostate cancer growth (54).”
BackgroundEndoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356
GRP78: A cell's response to stress
Ibrahim, I. M., Abdelmalek, D. H., & Elfiky, A. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.022 · Cited by 647
“These results are in agreement with other types of cancers such as colon cancer [92], and prostate cancer [93].”
Wang, M., Wey, S., Zhang, Y., Ye, R., & Lee, A. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2485 · Cited by 609
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
Lee, A. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3701 · Cited by 587
Luo, B., & Lee, A. S. (2013) · Oncogene · doi:10.1038/onc.2012.130 · Cited by 560
Endoplasmic Reticulum and the Unfolded Protein Response
(2013) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-407704-1.00005-1 · Cited by 548
“Also, in a transgene-induced breast cancer model, BiP/GRP78 was shown to favor tumor proliferation and angiogenesis (Fu et al., 2008; Dong et al., 2011).”
BackgroundKim, C., & Kim, B. (2018) · Nutrients · doi:10.3390/nu10081021 · Cited by 493
“For example, the knockout of GRP78 resulted in decreased proliferation rates of glioma cells and suppressed PTEN null prostate tumorigenesis and AKT oncogenic pathway [34,38].”
BackgroundER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
Hart, L. S., Cunningham, J. T., Datta, T., Dey, S., Tameire, F., Lehman, S. L., Qiu, B., Zhang, H., Cerniglia, G., Bi, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62973 · Cited by 433
Endoplasmic Reticulum Stress and Cancer
Yadav, R. K., Chae, S.-W., Kim, H.-R., & Chae, H. J. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.75 · Cited by 393
The critical role of GRP78 in physiologic and pathologic stress
Pfaffenbach, K. T., & Lee, A. S. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.09.007 · Cited by 327
“Mouse with homozygous deletion of Pten in the prostate epithelium presents an excellent model for prostate cancer development as it mimics human pathology [38 ].”
BackgroundInfluentialTumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
“Further, suppression of BiP signaling by KP1339 (also known as IT-139) or HA15 in glioblastoma, bladder or breast cancer cell lines has been shown to enhance the response to anti-cancer therapy [194, 195].”
BackgroundZhu, G., & Lee, A. S. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24923 · Cited by 299
“Homozygous deletion of Grp78 specifically in prostate epitheliumofGrp78f/f; Probasin-Cremice did not affect postnatal prostate development or the fertility of the mouse (Fu et al., 2008).”
BackgroundTransmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells
Mahadevan, N. R., Rodvold, J., Sepulveda, H., Rossi, S., Drew, A. F., & Zanetti, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008942108 · Cited by 294
“IncreasedGRP78 expression in human prostate cancer correlates with recurrence and poor survival (12), and conditional deletion of Grp78 in the prostates of Pten-deficient mice abrogates prostate tumorigenesis (13).”
BackgroundGRP78 at the Centre of the Stage in Cancer and Neuroprotection
Casas, C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00177 · Cited by 220
“…bi-allelic conditional knockouts of both GRP78 and PTEN in the prostate epithelium, prostate tumorigenesis was potently arrested, providing the first evidence that GRP78 is required for tumorigenesis driven by loss of PTEN and activation of the PI3K/AKT oncogenic pathway (Fu et al., 2008).”
BackgroundKelber, J. A., Panopoulos, A. D., Shani, G., Booker, E. C., Belmonte, J. C., Vale, W. W., & Gray, P. C. (2009) · Oncogene · doi:10.1038/onc.2009.97 · Cited by 180
“In addition, tumorigenesis and Akt activation resulting from Pten loss in prostate epithelium is blocked by prostatespecific disruption of GRP78 expression (Fu et al., 2008), consistent with the ability of cell surface GRP78 to initiate Akt signaling.”
BackgroundLiu, R., Li, X., Gao, W., Zhou, Y., Wey, S., Mitra, S. K., Krasnoperov, V., Dong, D., Liu, S., Li, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1106 · Cited by 180
“Inmiceharboring biallelic conditional knockout ofboth GRP78 and tumor suppressor PTEN in the prostate epithelium, prostate tumorigenesis was potently arrested (10).”
BackgroundYe, R., Jung, D. Y., Jun, J. Y., Li, J., Luo, S., Ko, H. J., Kim, J. K., & Lee, A. S. (2010) · Diabetes · doi:10.2337/db09-0755 · Cited by 173
The paradox of the unfolded protein response in cancer.
Vandewynckel, Y., Laukens, D., Geerts, A. M., Bogaerts, E., Paridaens, A., Verhelst, X., Janssens, S., Heindryckx, F., & Vlierberghe, H. V. (2013) · PubMed · Cited by 201
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer
Hu, Y., Chen, H.-Y., Yu, C.-Y., Xu, J., Wang, J.-L., Qian, J., Zhang, X., & Fang, J.-Y. (2014) · Oncotarget · doi:10.18632/oncotarget.1895 · Cited by 159
“So far, only KRAS mutation analysis has been used in clinical practice as a predictive marker for the effect of EGFR antibodies in metastatic disease [12-16].”
Wang, M., Ye, R., Barron, E., Baumeister, P., Mao, C., Luo, S., Fu, Y., Luo, B., Dubeau, L., Hinton, D. R., et al. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.144 · Cited by 159
Yung, H. W., Charnock-Jones, D. S., & Burton, G. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017894 · Cited by 158
“The ER-specific chaperone, GRP78, has recently been reported to regulate AKT phosphorylation at the Ser473 residue [22,23].”
Ni, M., Zhou, H., Wey, S., Baumeister, P., & Lee, A. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006868 · Cited by 156
Zhang, Y., Tseng, C.-C., Tsai, Y.-L., Fu, X., Schiff, R., & Lee, A. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080071 · Cited by 149
“not only critically required for prostate tumorigenesis and leukemogenesis, it is also required for AKT activation both in vivo and in vitro [35,49].”
BackgroundMahadevan, N. R., Anufreichik, V., Rodvold, J. J., Chiu, K. T., Sepulveda, H., & Zanetti, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051845 · Cited by 148
“UPR signaling pathways are activated in primary solid tumors of diverse histological origin, but not in peritumoral areas, and ablation of UPR elements prevents tumor initiation or significantly decreases tumor growth, survival, and angiogenesis [5,6,7,8].”
BackgroundDong, D., Stapleton, C. J., Luo, B., Xiong, S., Ye, W., Zhang, Y., Jhaveri, N., Zhu, G., Ye, R., Liu, Z., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3151 · Cited by 163
“studies that patients with high GRP78 expression levels in their tumors generally have a poorer prognosis and experience earlier relapse (3, 9, 11, 21, 26, 27).”
Ji, C., Kaplowitz, N., Lau, M. Y., Kao, E., Petrovic, L. M., & Lee, A. S. (2011) · Hepatology · doi:10.1002/hep.24368 · Cited by 145
“Polymerase chain reaction (PCR) genotyping with tail or liver genomic DNA was performed to distinguish Grp78 alleles of wild-type (WT), floxed, and deleted mice.(9) The presence and quantity of the albumin (Alb)-Cre transgene were determined by duplex quantitative PCR with Cre-specific primers (Supporting Table 1).”
MethodGlucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 167
“GRP78 promotes the activation of Akt in both solid tumor and leukemic cells [71,96–98].”
BackgroundNiederreiter, L., Fritz, T. M. J., Adolph, T. E., Krismer, A.-M., Offner, F. A., Tschurtschenthaler, M., Flak, M. B., Hosomi, S., Tomczak, M. F., Kaneider, N. C., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122341 · Cited by 139
“Human tumor cells indeed exhibit evidence of ER stress, and reduced capacity to elicit an UPR within malignant cells results in decreased tumorigenesis in model systems (Ma and Hendershot, 2004; Bi et al., 2005; Fu et al., 2008; Luo and Lee, 2013).”
BackgroundRoller, C., & Maddalo, D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00010 · Cited by 134
“ATF4 induces the transcription factor CHOP/GADD134 (Fawcett et al., 1999) that in turn induces the pro-apoptotic protein Bax (Yamaguchi and Wang, 2004) and Bim (Puthalakath et al., 2007) and inhibits the anti-apoptotic protein Bcl-2 (McCullough et al., 2001).”
BackgroundSu, S., Chang, Y.-W., Andreu‐Vieyra, C., Fang, J., Yang, Z., Han, B., Lee, A. S., & Liang, G. (2012) · Oncogene · doi:10.1038/onc.2012.483 · Cited by 145
Tameire, F., Verginadis, I. I., & Koumenis, C. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.04.002 · Cited by 129
“Specifically, GRP78 was shown to promote tumorigenesis hrough the regulation of proliferation, invasion and metastasis, ngiogenesis as well as therapy resistance through extensive studes in cell culture and transgenic mouse models of cancer [18–21].”
BackgroundRecent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
Lee, J., Choi, M., & Song, I. (2023) · Pharmaceuticals · doi:10.3390/ph16060802 · Cited by 160
“Colon and prostate cancer cells have shown high GRP78 expression during treatment with celecoxib [86,87].”
BackgroundNakajima, S., Hiramatsu, N., Hayakawa, K., Saito, Y., Kato, H., Huang, T., Yao, J. Q., Paton, A. W., Paton, J. C., & Kitamura, M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00939-10 · Cited by 119
“Of note, some investigators reported that targeted knockout of BiP/GRP78 in the prostate epithelium suppressed Akt activation and tumorigenesis (11).”
Cancer-Associated Fibroblasts Enhance the Gland-Forming Capability of Prostate Cancer Stem Cells
Liao, C.-P., Adisetiyo, H., Liang, M., & Roy-Burman, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3982 · Cited by 110
“GRP78, a major ER chaperone is reported to be highly induced in a wide range of tumors including prostate cancer (41), and we described that loss of GRP78 in the prostatic epithelium can prevent prostate tumor formation in the Pten deletion model (32).”
Rodvold, J. J., Chiu, K., Hiramatsu, N., Nussbacher, J. K., Galimberti, V., Mahadevan, N. R., Willert, K., Lin, J. H., & Zanetti, M. (2017) · Science Signaling · doi:10.1126/scisignal.aah7177 · Cited by 120
“In support of the former, conditional homozygous knockout (KO) of Grp78 in the prostate of mice with Pten inactivation protects against cancer growth (11), whereas the inactivation of PERK or expression of a dominant-negative PERK mutant in cancer cells yields smaller and less aggressive tumors inmice (12).”
BackgroundWu, M., Jan, C.-I., Tsay, Y., Yu, Y., Huang, C., Lin, S., Liu, C., Chen, Y., Lo, J., & Yu, C.-C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-283 · Cited by 108
“It is reasonable that GRP78 signaling may not be the only one pathway in contributing in the regulation of HN-CICs, although, we and others observed that GRP78 regulates Wnt5A and PTEN-PI3K-Akt expression [54].”
BackgroundThe unfolded protein response as a target for cancer therapy
Nagelkerke, A., Bussink, J., Sweep, F. C. G. J., & Span, P. N. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.006 · Cited by 115
“Multiple studies have shown that GRP78 is critical for tumour progression [8,56,57].”
BackgroundWang, J., Yin, Y., Hua, H., Li, M., Luo, T. L., Xu, L., Wang, R., Liu, D., Zhang, Y., & Jiang, Y. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00873.x · Cited by 107
“Moreover, it has been demonstrated that GRP78 is involved in Akt phosphorylation [46].”
BackgroundCell Intrinsic Role of COX-2 in Pancreatic Cancer Development
Hill, R., Li, Y., Tran, L. M., Dry, S., Calvopina, J. H., Garcia, A., Kim, C., Wang, Y., Donahue, T. R., Herschman, H. R., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0342 · Cited by 99
“20 Pten null prostate tumorigenesis, leukemia development and AKT activation (40, 41), suggesting GRP78 as a potential therapeutic target for cancers that result from PTEN loss or inactivation.”
Won, S., Lee, H., Jeong, S., Lee, H.-J., Lee, E., Jung, D., Shin, J.-M., Kwon, T., Yun, S.-M., Lee, M., et al. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1828 · Cited by 91
Wey, S., Luo, B., Tseng, C.-C., Ni, M., Zhou, H., Fu, Y., Bhojwani, D., Carroll, W. L., & Lee, A. S. (2011) · Blood · doi:10.1182/blood-2011-06-357384 · Cited by 94
Baumeister, P., Dong, D., Fu, Y., & Lee, A. S. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1166 · Cited by 89
Lin, Y., Wang, Z., Liu, L., & Chen, L. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.06.004 · Cited by 87
Misra, U. K., & Pizzo, S. V. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.2.10422 · Cited by 92
“GRP78 participates in ER protein translocation, chaperoning, ER-associated protein degradation, and ER calcium binding.(29,30) Overexpression of GRP78 promotes tumor proliferation, metastasis and drug resistance.”
BackgroundCripto/GRP78 modulation of the TGF‐β pathway in development and oncogenesis
Gray, P. C., & Vale, W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.051 · Cited by 103
“Consistent with these studies, tumorigenesis and Akt activation resulting from Pten loss was blocked by conditional knockout of GRP78 expression both in prostate epithelium [141] and the hematopoietic system [142].”
BackgroundMahadevan, N. R., & Zanetti, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101531 · Cited by 92
“Similarly, the conditional homozygous knockout of Grp78 in the prostates of mice with Pten inactivation protects against prostate cancer growth (34).”
BackgroundAlbakova, Z., Mangasarova, Y., Albakov, A., & Gorenkova, L. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.829520 · Cited by 98
HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances
Zhao, K., Zhou, G.-Y., Liu, Y., Zhang, J., Chen, Y., Liu, L.-X., & Zhang, G. (2023) · Biomolecules · doi:10.3390/biom13040601 · Cited by 73
Rao, R., Nalluri, S., Kolhe, R. B., Yang, Y., Fiskus, W. C., Chen, J., Ha, K., Buckley, K. M., Balusu, R., Coothankandaswamy, V., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0988 · Cited by 95
“Conversely, homozygous deletion of GRP78 in prostate epithelium inhibits prostate tumorigenesis (17).”
BackgroundProstate cancer and the unfolded protein response
Storm, M. L., Sheng, X., Arnoldussen, Y. J., & Saatcioglu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9912 · Cited by 87
“Consistently, double knockout of Bip and Pten in prostates of mice completely reverts the invasive adenocarcinoma phenotype normally observed upon Pten deletion, further establishing BiP as a key regulator of PCa progression [85].”
Bennett, H. L., Fleming, J., O’Prey, J., Ryan, K. M., & Leung, H. Y. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.50 · Cited by 86
Chen, W.-T., Zhu, G., Pfaffenbach, K. T., Kanel, G. C., Stiles, B. L., & Lee, A. S. (2013) · Oncogene · doi:10.1038/onc.2013.437 · Cited by 81
Liu, C., Su, G., Giesy, J. P., Letcher, R. J., Li, G., Agrawal, I., Li, J., Yu, L., Wang, J., & Gong, Z. (2016) · Scientific Reports · doi:10.1038/srep19045 · Cited by 77
Liao, C., Lin, T., Li, P., Geary, L., Chen, K., Vaikari, V. P., Wu, B. J., Lin, C., Gross, M. E., & Shih, J. C. (2018) · Oncogene · doi:10.1038/s41388-018-0325-x · Cited by 77
“By combining with other loxP models such as GRP78 [15] or survivin [16], recent studies have shown the efficiency of ARR2PBCre in inactivating Pten and associated target genes in prostate epithelium.”
MethodMyeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Bujanda, Z. A. L., & Drake, C. G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5vmr1116-491rr · Cited by 78
“Furthermore, PI3K/PTEN/AKT activation was found to be abrogated by HSPA5 deletion in a PTEN conditional knockout mouse model [109].”
BackgroundAkinyemi, A. O., Simpson, K. E., Oyelere, S. F., Nur, M., Ngule, C. M., Owoyemi, B. C. D., Ayarick, V. A., Oyelami, F., Obaleye, O. E., Esoe, D.-P. I., et al. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00706-6 · Cited by 73
Chen, W., Tseng, C.-C., Pfaffenbach, K. T., Kanel, G. C., Luo, B., Stiles, B. L., & Lee, A. S. (2013) · Hepatology · doi:10.1002/hep.26711 · Cited by 67
“Genotyping by polymerase chain reaction (PCR) was previously described.(12) Blood samples were collected through retro-orbital bleeding.”
MethodTan, S. S. Y., Ahmad, I., Bennett, H. L., Singh, L. B., Nixon, C., Seywright, M. M., Barnetson, R. J., Edwards, J., & Leung, H. Y. (2010) · The Journal of Pathology · doi:10.1002/path.2795 · Cited by 73
ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner
Mahadevan, N. R., Rodvold, J. J., Almanza, G., Fernandez-Perez, A., Wheeler, M. C., & Zanetti, M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-229 · Cited by 70
“[16] demonstrated that prostate-specific knockdown of Grp78 in Pten-null mice abrogates AKT phosphorylation (and tumor development), and that human prostate cancer cells under ER stress increase AKT phosphorylation in a Grp78-dependent manner.”
BackgroundTUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo
Horak, P., Tomasich, E., Vaňhara, P., Vašíčková, K., Anees, M., Marhold, M., Lemberger, C. E., Gerschpacher, M., Horvat, R., Sibilia, M. C., et al. (2014) · Scientific Reports · doi:10.1038/srep03739 · Cited by 68
Site-specific activation of AKT protects cells from death induced by glucose deprivation
Gao, M., Liang, J., Lu, Y., Guo, H., German, P., Bai, S., Jonasch, E., Yang, X., Mills, G. B., & Ding, Z. (2013) · Oncogene · doi:10.1038/onc.2013.2 · Cited by 67
Wey, S., Luo, B., & Lee, A. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039047 · Cited by 62
“Mice Grp78 mice in a mixed C57BL/6;129/Sv background [11,14] were crossed with the transgenic Mx-1-Cre mice in a C57BL/6 background (Jackson Laboratory) to generate Grp78 ;Mx-1-Cre mice.”
BackgroundMethodInfluentialMimeault, M., & Batra, S. K. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00115 · Cited by 62
Gutiérrez, T., & Simmen, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00291 · Cited by 62
“In contrast, low levels of BiP/GRP78 tend to have opposite effects in mice and result in decreased activity of PI3K signaling in prostate and leukemia cancer models (149, 150).”
BackgroundFOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis
Wang, J., Liu, S., Yin, Y., Li, M., Wang, B., Yang, L., & Jiang, Y. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1071-3 · Cited by 58
Chiu, C., Lin, C., Lee, L., Chen, Y., Lu, Y.-C., Wang, H., Liao, C.-T., Chang, J. T., & Cheng, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2107 · Cited by 58
“091 Total 78 35 (45) 43 (55) 38 (49) 40 (51) 42 (54) 36 (46) 48 (61) 30 (39)”
BackgroundKIAA1324 Suppresses Gastric Cancer Progression by Inhibiting the Oncoprotein GRP78
Kang, J. M., Park, S., Kim, S. J., Kim, H.-J., Lee, B., Kim, J., Park, J., Kim, S. T., Yang, H., Kim, W. H., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3751 · Cited by 63
Wakasa, Y., Hayashi, S., & Takaiwa, F. (2012) · Planta · doi:10.1007/s00425-012-1714-y · Cited by 57
“Keywords BiP bZIP50 Endoplasmic reticulum (ER) ER stress IRE1 Oryza Transgenic rice”
InfluentialMelanoma and the Unfolded Protein Response
Sykes, E. K., Mactier, S., & Christopherson, R. I. (2016) · Cancers · doi:10.3390/cancers8030030 · Cited by 63
“In mouse models for breast and prostate cancer, GRP78 knock-out protects against cancer growth [50], proliferation and angiogenesis [51].”
BackgroundJoshi, M., Kim, J., D’Alessandro, A., Monk, E., Bruce, K., Elajaili, H., Nozik-Grayck, E., Goodspeed, A., Costello, J. C., & Schlaepfer, I. R. (2020) · Cancers · doi:10.3390/cancers12113431 · Cited by 54
“Indeed, conditional knockout of the ER chaperone GRP78 (HSPA5) in the prostate of mice with PTEN inactivation suppressed prostate cancer growth [24].”
BackgroundBacker, J. M., Krivoshein, A. V., Hamby, C. V., Pizzonia, J. H., Gilbert, K. S., Ray, Y. S., Brand, H., Paton, A. W., Paton, J. C., & Backer, M. V. (2009) · Neoplasia · doi:10.1593/neo.09878 · Cited by 54
“The dependence on GRP78/BiP for cell survival is cell specific [25,26].”
BackgroundShen, J., Ha, D. P., Zhu, G., Rangel, D. F., Kobielak, A., Gill, P. S., Groshen, S. G., Dubeau, L., & Lee, A. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616060114 · Cited by 58
Tan, M., Xu, J., Siddiqui, J., Feng, F. Y.-C., & Sun, Y. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0567-6 · Cited by 52
“It develops through successive stages including intraepithelial neoplasia (PIN), carcinoma in situ, invasive adenocarcinoma, and metastatic diseases [2].”
Liu, D., Yang, Q., Jin, S., Song, Y., Gao, J., Wang, Y., & Mi, H. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.10.007 · Cited by 50
GRP78/BiP is a novel downstream target of IGF‐1 receptor mediated signaling
Pfaffenbach, K. T., Pong, M., Morgan, T. E., Wang, H., Ott, K., Zhou, B., Longo, V. D., & Lee, A. S. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24090 · Cited by 50
Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation
Hu, F., Yu, C., Hsieh, P., Liao, Y., Lu, M., & Chu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21338 · Cited by 50
“Likewise, blockage of GRP78 expression suppresses tumorigenesis and Akt activation with PTEN loss in prostate epithelium [55].”
BackgroundBakewell, S. J., Rangel, D. F., Ha, D. P., Sethuraman, J., Crouse, R., Hadley, E., Costich, T. L., Zhou, X., Nichols, P. W., & Lee, A. S. (2018) · Oncotarget · doi:10.18632/oncotarget.25679 · Cited by 55
Endoplasmic reticulum stress is activated in endometrial adenocarcinoma
Bifulco, G., Miele, C., Jeso, B. D., Bèguinot, F., Nappi, C., Carlo, C. D., Capuozzo, S., Terrazzano, G., Insabato, L., & Ulianich, L. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.11.045 · Cited by 52
“Knockout of GRP78 in prostate epithelium has been reported to inhibit prostate cancer formation inmice [23].”
BackgroundHussien, Y., Podojil, J. R., Robinson, A. P., Lee, A. S., Miller, S. D., & Popko, B. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0693-15.2015 · Cited by 53
“Although homozygous knock-out of the BiP gene in prostate epithelial cells has little effect on mouse prostate development and function (Fu et al., 2008), most cells and organs in which BiP function has been analyzed have shown a critical need for basal BiP expression (Wang et al.”
BackgroundMethodGRP78 plays an essential role in adipogenesis and postnatal growth in mice
Zhu, G., Ye, R., Jung, D. Y., Barrón, E., Friedline, R. H., Benoit, V. M., Hinton, D. R., Kim, J. K., & Lee, A. S. (2012) · The FASEB Journal · doi:10.1096/fj.12-213330 · Cited by 52
“The generation of Grp78 mice was described previously (10, 11).”
MethodThe evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
Zanetti, M., Rodvold, J. J., & Mahadevan, N. R. (2015) · Oncogene · doi:10.1038/onc.2015.108 · Cited by 51
Oida, T., & Weiner, H. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904121 · Cited by 53
“Although GRP78 knockout mice are embryonic lethal (31), Cre-mediated conditional GRP78 knockout mice have been reported (32), and, thus, cell- or organ-specific conditional knockout animals would be helpful to address these issues.”
The endoplasmic reticulum stress response in prostate cancer
de la Calle, C. M., Shee, K., Yang, H., Lonergan, P. E., & Nguyen, H. G. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00649-3 · Cited by 50
Gray, M. J., Mhawech-Fauceglia, P. Y., Yoo, E.-J., Yang, W., Wu, E., Lee, A. S., & Lin, Y. G. (2012) · International Journal of Cancer · doi:10.1002/ijc.27994 · Cited by 51
Hsieh, T., Lin, C., Lin, H., & WU, J. M. (2012) · ISRN Urology · doi:10.5402/2012/272697 · Cited by 49
“AKT is robustly activated in various cancers and the AKT signaling cascade is well integrated with growthfactor-mediated pathways in CaP, having implications in CaP survival and development [41, 43].”
BackgroundTargeting GRP78 to enhance melanoma cell death
Martin, S., Hill, D. S., Paton, J. C., Paton, A. W., Birch‐Machin, M. A., Lovat, P. E., & Redfern, C. P. F. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00731.x · Cited by 50
“…Zhuang et al., 2009) and the inhibition or down-regulation of GRP78 can increase ER stress-induced death (Rao et al., 2002; Reddy et al., 2003), inhibit tumorigenesis of prostate cancer cells (Fu et al., 2008) and prevent the development of resistance to cytotoxic T cells (Sugaw- ara et al., 1993).”
Zhang, J., Wen, H.-J., Guo, Z.-M., Zeng, M., Li, M.-Z., Jiang, Y.-E., He, X.-G., & Sun, C. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.06.512 · Cited by 45
Mashima, T., Soma‐Nagae, T., Migita, T., Kinoshita, R., Iwamoto, A., Yuasa, T., Yonese, J., Ishikawa, Y., & Seimiya, H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3718 · Cited by 54
Glucose-regulated protein 78 is essential for cardiac myocyte survival
Wang, X., Bi, X., Zhang, G., Deng, Y., Luo, X., Xu, L., Scherer, P. E., Ferdous, A., Fu, G., Gillette, T. G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0109-4 · Cited by 47
“To engineer cardiac-specific knockout of GRP78, the GRP78 mouse [18, 19] was crossed with cardiomyocytespecific Cre (αMHC-Cre) mouse model.”
MethodMafi, S., Ahmadi, E., Meehan, E. V., Chiari, C. C., Mansoori, B., Sadeghi, H., Milani, S., Jafarinia, M., Taeb, S., Bashmagh, B. M., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3032 · Cited by 47
Xing, X., Li, Y., Liu, H., Wang, L., & Sun, L. (2010) · Acta Histochemica · doi:10.1016/j.acthis.2010.11.006 · Cited by 48
“…level of GRP78 is one of the results of UPR (unfolding rotein response), while other studies suggest, besides the UPR, nother signaling pathway containing activation of the PKC, PKA, kt and ERK is also involved in the induced GRP78 expression (Song t al., 2001; Chang et al., 2003; Fu et al., 2008).”
BackgroundLuo, B., Lam, B. S., Lee, S. H., Wey, S., Zhou, H., Wang, M., Chen, S., Adams, G. B., & Lee, A. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020364 · Cited by 41
“Genotyping was performed by PCR using genomic DNA extracted from mouse tail biopsies as previously described [58].”
MethodProteostasis in the Endoplasmic Reticulum: Road to Cure
Nam, S. M., & Jeon, Y. J. (2019) · Cancers · doi:10.3390/cancers11111793 · Cited by 50
Decreased expression of endoplasmic reticulum chaperone GRP78 in liver of diabetic mice
Yamagishi, N., Ueda, T., Mori, A., Saito, Y., & Hatayama, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.118 · Cited by 45
“A recent report has shown that targeted knockout of GRP78 suppresses the activation of AKT, a serine/threonine kinase that regulates growth factor signaling, and blocks tumorigenesis of Pten-null prostate epithelium cancer [29].”
BackgroundLuo, C., Xiong, H., Chen, L., Liu, X., Zou, S., Guan, J., & Wang, K. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.02.007 · Cited by 42
Immune modulation by ER stress and inflammation in the tumor microenvironment
Rodvold, J. J., Mahadevan, N. R., & Zanetti, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.09.009 · Cited by 44
Flodby, P., Li, C., Liu, Y., Wang, H., Marconett, C. N., Laird‐Offringa, I. A., Minoo, P., Lee, A. S., & Zhou, B. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0327oc · Cited by 39
“Tissue-specific Grp78 KO induced ER stress/apoptosis in Purkinje and liver cells (38, 39), but no abnormalities in prostate epithelial cells (40, 41).”
BackgroundRahimi, S., Roushandeh, A. M., Ahmadzadeh, E., Jahanian‐Najafabadi, A., & Roudkenar, M. H. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05261-5 · Cited by 40
Vietri, M., Miranda, M. R., Amodio, G., Ciaglia, T., Bertamino, A., Campiglia, P., Remondelli, P., Vestuto, V., & Moltedo, O. (2025) · Biomolecules · doi:10.3390/biom15070930 · Cited by 43
Metadata
- Authors
- Fu, Y., Wey, S., Wang, M., Ye, R., Liao, C.-P., Roy-Burman, P., & Lee, A. S.
- Affiliations
- University of Southern California (US)
- Departments of aBiochemistry and Molecular Biology and
- Pathology, University of Southern California Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, Los Angeles, CA 90089-9176
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-12-09
- Volume
- 105
- Issue
- 49
- Pages
- 19444-19449
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2614780
- OpenAlex
- W2008683065
- Cited by
- 180
- References
- 31
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 5 · 2018: 10 · 2017: 12 · 2016: 10 · 2015: 9 · 2014: 20 · 2013: 14 · 2012: 16
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Southern California
- University of California, Los Angeles
- National Cancer Institute (CA 113392, R01CA027607, CA27607, R01CA113392)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- GRP78, PTEN, prostate cancer, prostate tumorigenesis, Akt activation, Akt phosphorylation, conditional knockout, prostate epithelium, ER chaperones, tumor suppressor loss, invasive adenocarcinoma, mouse model
- MeSH terms
- Endoplasmic Reticulum Chaperone BiP, Adenocarcinoma, Animals, Epithelium, Fluorescent Antibody Technique, Heat-Shock Proteins, Homozygote, Male, Mice, Inbred C57BL, Prostate, Prostatic Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Mice, Knockout, Molecular Chaperones, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.